Nominations for the 2014 award are closed.
The AACR-Women in Cancer Research Charlotte Friend Memorial Lectureship was established in 1998 in honor of renowned virologist and discoverer of the Friend virus, Dr. Charlotte Friend, for her pioneering research on viruses, cell differentiation and cancer. The lecture is intended to give recognition to an outstanding female or male scientist who has made meritorious contributions to the field of cancer research and who has, through leadership or by example, furthered the advancement of women in science.
The recipient of the award will receive an honorarium of $5,000, give a 50-minute lecture during the AACR Annual Meeting 2014 in San Diego, Calif. (April 5-9, 2014), and will be provided support for the winner and a guest to attend the AACR Annual Meeting 2014.
- Candidacy is open to all cancer researchers who are affiliated with any institution involved in cancer research, cancer medicine or cancer-related biomedical science anywhere in the world. Such institutions include those in academia, industry or government.
- The lectureship will be presented to an individual investigator.
- Institutions or organizations are not eligible for the lectureship.
Nominations are closed.
Nominations may be made by any scientist, whether an AACR member or nonmember, who is now or has been affiliated with any institution involved in cancer research, cancer medicine or cancer-related biomedical science. Candidates may not nominate themselves.
Nomination Procedure and Instructions
Nominations must be emailed to email@example.com by 4:00 p.m. United States Eastern Time on Thursday, October 3, 2013. Paper nominations will not be accepted.
Nomination Materials to be Submitted are:
1) Nomination Letter Must:
- be addressed to the Selection Committee; be written in English; and not exceed 1,000 words;
- specify the AACR Award for which the candidate is being nominated;
- describe the candidate’s contributions to the field of cancer research; the publications supporting these contributions must be directly referenced within the letter. The letter must also describe how the candidate has, through leadership or by example, furthered the advancement of women in science; and
- be signed by the nominator(s).
2) Candidate's CV. The candidate's curriculum vitae in English, including a complete list of the candidate's publications.
3) Summary Statement. A statement, no more than 50 words, summarizing the candidate's research accomplishments for which he or she is being nominated.
Full nomination instructions and program guidelines are available through the link below.
Candidates will be considered by a Selection Committee of international cancer leaders appointed by the president of the AACR. After careful deliberations by the committee, its recommendations will be forwarded to the Executive Committee of the AACR for final consideration and decision. Selection of the winner will be made on the basis of the candidate's contributions to the field of cancer research and to the advancement of women in science. No regard will be given to age, race, gender, nationality, geographic location or religious or political views.
Linda Stokes, Program Associate
American Association for Cancer Research
17th Floor, 615 Chestnut Street
Philadelphia, PA 19106-4404
16th Annual Lectureship Recipient
Guillermina Lozano, Ph.D.
Professor and Chair
Department of Genetics
The University of Texas MD Anderson Cancer Center
Dr. Lozano delivered her award lecture titled Activities of Mutant p53 Proteins in Cancer, at the AACR Annual Meeting 2013 in Washington, D.C. The award ceremony and lecture was held on Saturday, April 6, 2013. Visit the AACR Annual Meeting 2013 page for more information on the Annual Meeting.
Dr. Guillermina Lozano is Professor and Chair of the Department of Genetics, and the Mattie Allen Fair Research Chair at The University of Texas MD Anderson Cancer Center. Dr. Lozano also serves as the Director of the Training Program in Molecular Genetics of Cancer, and Co-Director of the Genomics Facility.
Dr. Lozano, an accomplished basic scientist with a national and international reputation, is recognized for her work as a cancer geneticist and her high-impact research on understanding the regulation of the p53 tumor suppression pathway and its physiologic significance in potential cancer therapy.
Dr. Lozano has made several landmark contributions to the field. She was the first to identify a transactivation domain in the p53 tumor suppressor. This is a fundamental discovery that led many investigators to identify the p53 DNA binding domains and transcriptional targets of p53. Dr. Lozano’s groundbreaking observation led to the understanding that embryonic lethality afforded by germ-line inactivation of Mdm2 is rescued by coincident deletion of germ-line p53. Her recognition of the critical role of Mdm2/Mdm4 in restraining p53 activity led to the therapeutic potential of targeted cancer therapy. Using a mouse model of Li-Fraumeni syndrome with inherent p53 missense mutation, Dr. Lozano was successful in distinguishing cell cycle arrest from apoptotic pathways. She also discovered gain-of-function properties of certain p53 missense mutations, which functionally inactivated p63 and p73 cells.
Her stature as a leading expert in her field is evidenced in part by her service on numerous NIH study sections and advisory boards, as well as participation as a member of the Damon Runyon Scientific Advisory Committee, the Burroughs Wellcome Fund Training Grant Review Committee, and many others. She is also the organizer of many national and international conferences. She has published over 135 papers in high-impact journals and has served as a reviewer for many of these journals. Dr. Lozano is an exemplary mentor and role model, and she has trained many women scientists who later developed their own successful careers.
More recently, Dr. Lozano received the AACR-MICR Jane Cooke Wright Lectureship for Cancer Research and UMDNJ-Graduate School of Biomedical Sciences Distinguished Alumnus Award. As such, Dr. Lozano is the 2013 recipient of the AACR-Women in Cancer Research Charlotte Friend Memorial Lectureship.